Lending support to his choice, Barclays analyst Lauren Lieberman, on May 21, maintained Coca-Cola with an Overweight rating and raised the price target from $85 to $89.
Don't forget to check out our premarket coverage here
Bill Baruch, founder and CIO of both Blue Line Capital, an investment advisor, and Blue Creek Capital Management, picked AbbVie Inc. (NYSE: ABBV ).
As per the recent news, AbbVie, on May 29, announced European Commission authorization of expanded label for VENCLYXTO® (venetoclax) to include additional combinations in previously untreated chronic lymphocytic leukemia.
Jenny Van Leeuwen Harrington, chief executive officer of Gilman Hill Asset Management, LLC, recommended Sabra Health Care REIT, Inc. (NASDAQ: SBRA ).
On the earnings front, Sabra Health Care, on April 29, posted better-than-expected results for the first quarter.
Stephen Weiss, chief investment officer and managing partner of Short Hills Capital Partners, named UnitedHealth Group Incorporated (NYSE: UNH ) as his final trade.
Supporting his view, B of A Securities analyst Kevin Fischbeck, on June 4, upgraded UnitedHealth Group from Neutral to Buy and raised the price target from $420 to $450.
Price Action:
Coca-Cola shares gained 3.5% to close at $79.48 on Friday. AbbVie shares rose 1% to settle at $227.23 during the session. Sabra Health Care shares gained 4.5% to close at $18.46 on Friday. UnitedHealth shares rose 0.8% to settle at $399.47 on Friday.Photo via Shutterstock
Market News and Data brought to you by Benzinga APIs© 2026 Benzinga.com. Benzinga does not provide investment advice. All rights reserved.
To add Benzinga News as your preferred source on Google, click here .
Posted In: Long Ideas News Media Trading Ideas Bill Baruch CNBC Halftime Report Final Trades Jenny Van Leeuwen Harrington Kevin Simpson .bz3-youtube-box-container { max-width: 360px; margin-bottom: 14px; } .bz3-youtube-box-container .section-block-header { display: none; }